QuiaPEG Pharmaceuticals Holding AB (QUIA) — Capital Reinvestment Ratio
Latest as of December 2015:
0.38x
QuiaPEG Pharmaceuticals Holding AB (QUIA) has a Capital Reinvestment Ratio of 0.38x as of December 2015, meaning it reinvests 0% of its operating cash flow (Skr487.00K) in capital expenditures (Skr184.00K). See QuiaPEG Pharmaceuticals Holding AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.38x
Capex / Operating Cash Flow
Operating Cash Flow
Skr487.00K
SEK
Capital Expenditures
Skr184.00K
SEK
Data as of
Dec 2015
Most recent filing
QuiaPEG Pharmaceuticals Holding AB Capital Reinvestment Ratio (2008–2015)
This chart tracks QuiaPEG Pharmaceuticals Holding AB's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for QuiaPEG Pharmaceuticals Holding AB (2008–2015)
Year-by-year Capital Reinvestment Ratio for QuiaPEG Pharmaceuticals Holding AB from 2008 to 2015. For live market cap and broader valuation context, see QUIA market cap.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.38x | Skr487.00K | Skr184.00K | ▲ +5518.2% |
| 2014 | 0.01x | Skr1.49 Million | Skr10.00K | ▼ -97.0% |
| 2011 | 0.22x | Skr2.55 Million | Skr573.00K | ▼ -12.2% |
| 2010 | 0.26x | Skr2.65 Million | Skr677.00K | ▲ +91.3% |
| 2009 | 0.13x | Skr1.82 Million | Skr244.00K | ▼ -96.2% |
| 2008 | 3.53x | Skr956.00K | Skr3.38 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow